Actively Recruiting
Two-channel IV-PCA With Dexmedetomidine
Led by Korea University Guro Hospital · Updated on 2025-01-03
110
Participants Needed
1
Research Sites
151 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Dexmedetomidine was administered in the 'selector' channel and fentanyl in the 'basic \& bolus' channel of dual channel intravenous patient-controlled analgesia (IV-PCA) and the amount of opioid consumption was compared. In addition, intensity of pain, postoperative nausea/vomiting, and postoperative delirium was evaluated.
CONDITIONS
Official Title
Two-channel IV-PCA With Dexmedetomidine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients scheduled for laparoscopic major abdominal surgery (gastrectomy, hepatectomy, colectomy, pancreatectomy) under general anesthesia
- Aged 20 years or older
You will not qualify if you...
- Body mass index greater than 35 kg/m2
- American Society of Anesthesiologists physical status greater than 3
- Severe cardiovascular disorder
- Severe liver or renal dysfunction
- Preoperative dyspnea
- Contraindication to dexmedetomidine (preoperative severe bradycardia with heart rate less than 50, atrioventricular block, allergy to dexmedetomidine)
- Preoperative use of opioid, anticonvulsant, or antidepressant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Korea University Guro Hospital
Seoul, South Korea
Actively Recruiting
Research Team
S
Seok Kyeong Oh, M.D., Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here